Jean-Philippe Desilles, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thrombectomy | 40 | 2024 | 705 | 3.750 |
Why?
|
Brain Ischemia | 39 | 2024 | 3049 | 3.500 |
Why?
|
Stroke | 60 | 2024 | 9757 | 2.750 |
Why?
|
Endovascular Procedures | 29 | 2024 | 2183 | 2.290 |
Why?
|
Intracranial Thrombosis | 6 | 2020 | 108 | 2.050 |
Why?
|
Infarction, Middle Cerebral Artery | 12 | 2023 | 485 | 1.920 |
Why?
|
Thrombolytic Therapy | 20 | 2024 | 2064 | 1.740 |
Why?
|
Tissue Plasminogen Activator | 13 | 2022 | 1164 | 1.430 |
Why?
|
Reperfusion | 8 | 2022 | 271 | 1.420 |
Why?
|
Thrombosis | 11 | 2024 | 2942 | 1.100 |
Why?
|
Fibrinolytic Agents | 14 | 2024 | 2084 | 0.820 |
Why?
|
Blood-Brain Barrier | 4 | 2018 | 1027 | 0.730 |
Why?
|
Deoxyribonuclease I | 1 | 2020 | 224 | 0.670 |
Why?
|
Cerebral Hemorrhage | 7 | 2023 | 2656 | 0.590 |
Why?
|
Venules | 1 | 2018 | 161 | 0.590 |
Why?
|
Pia Mater | 1 | 2018 | 87 | 0.590 |
Why?
|
Cerebral Infarction | 4 | 2021 | 983 | 0.580 |
Why?
|
Registries | 13 | 2021 | 8224 | 0.550 |
Why?
|
Astrocytes | 1 | 2024 | 1346 | 0.530 |
Why?
|
Arterial Occlusive Diseases | 6 | 2023 | 748 | 0.530 |
Why?
|
Carotid Stenosis | 5 | 2023 | 860 | 0.520 |
Why?
|
Microvessels | 2 | 2017 | 577 | 0.480 |
Why?
|
Embolization, Therapeutic | 7 | 2023 | 1418 | 0.480 |
Why?
|
Treatment Outcome | 51 | 2024 | 64680 | 0.450 |
Why?
|
Intracranial Aneurysm | 5 | 2023 | 1285 | 0.440 |
Why?
|
Microcirculation | 1 | 2018 | 1273 | 0.430 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2022 | 2751 | 0.420 |
Why?
|
Intracranial Arteriovenous Malformations | 3 | 2020 | 366 | 0.410 |
Why?
|
Carotid Artery, Internal | 6 | 2024 | 445 | 0.410 |
Why?
|
Cerebrovascular Circulation | 3 | 2018 | 2727 | 0.410 |
Why?
|
Reperfusion Injury | 1 | 2019 | 1023 | 0.400 |
Why?
|
Sinus Thrombosis, Intracranial | 2 | 2024 | 110 | 0.380 |
Why?
|
Stents | 9 | 2024 | 3179 | 0.370 |
Why?
|
Blood Pressure | 10 | 2023 | 8481 | 0.370 |
Why?
|
Patient Admission | 2 | 2019 | 1367 | 0.350 |
Why?
|
Diffusion Magnetic Resonance Imaging | 7 | 2020 | 2790 | 0.340 |
Why?
|
Fibrinolysis | 2 | 2022 | 332 | 0.340 |
Why?
|
Cerebral Angiography | 5 | 2021 | 1281 | 0.310 |
Why?
|
Hyperglycemia | 1 | 2017 | 1376 | 0.310 |
Why?
|
Venous Thrombosis | 1 | 2018 | 1303 | 0.310 |
Why?
|
Carotid Artery Diseases | 3 | 2023 | 877 | 0.310 |
Why?
|
Magnetic Resonance Angiography | 4 | 2020 | 1432 | 0.310 |
Why?
|
Anterior Cerebral Artery | 2 | 2018 | 50 | 0.300 |
Why?
|
Endarterectomy, Carotid | 2 | 2023 | 555 | 0.290 |
Why?
|
Cerebral Revascularization | 3 | 2016 | 259 | 0.280 |
Why?
|
Inflammation | 5 | 2024 | 10773 | 0.280 |
Why?
|
Aged, 80 and over | 30 | 2024 | 58976 | 0.270 |
Why?
|
Adenosine Monophosphate | 3 | 2022 | 231 | 0.260 |
Why?
|
Arteriovenous Fistula | 2 | 2020 | 319 | 0.260 |
Why?
|
Blood Pressure Determination | 2 | 2020 | 633 | 0.250 |
Why?
|
Aged | 45 | 2024 | 169289 | 0.250 |
Why?
|
Prospective Studies | 20 | 2024 | 54425 | 0.230 |
Why?
|
Middle Aged | 46 | 2024 | 220895 | 0.230 |
Why?
|
Male | 55 | 2024 | 360804 | 0.220 |
Why?
|
Humans | 88 | 2024 | 761504 | 0.220 |
Why?
|
Blood Glucose | 2 | 2019 | 6391 | 0.220 |
Why?
|
Ischemic Attack, Transient | 2 | 2023 | 882 | 0.210 |
Why?
|
Blood Platelets | 5 | 2021 | 2479 | 0.210 |
Why?
|
Rats, Sprague-Dawley | 4 | 2018 | 8181 | 0.200 |
Why?
|
Neutrophils | 4 | 2024 | 3767 | 0.200 |
Why?
|
Intracranial Hemorrhages | 4 | 2022 | 822 | 0.200 |
Why?
|
Recovery of Function | 4 | 2024 | 2979 | 0.200 |
Why?
|
France | 5 | 2024 | 497 | 0.200 |
Why?
|
Collateral Circulation | 2 | 2020 | 294 | 0.190 |
Why?
|
Janus Kinase 2 | 1 | 2024 | 560 | 0.180 |
Why?
|
Female | 49 | 2024 | 392644 | 0.180 |
Why?
|
Leukocytes | 3 | 2019 | 2026 | 0.180 |
Why?
|
Rats | 6 | 2020 | 23742 | 0.180 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15842 | 0.180 |
Why?
|
Apolipoprotein A-I | 1 | 2020 | 299 | 0.160 |
Why?
|
Hemostasis | 1 | 2021 | 467 | 0.160 |
Why?
|
Color | 1 | 2019 | 299 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 11 | 2023 | 36426 | 0.150 |
Why?
|
Hypertension | 4 | 2022 | 8540 | 0.150 |
Why?
|
Aerosols | 1 | 2020 | 635 | 0.150 |
Why?
|
Disease Models, Animal | 8 | 2024 | 18252 | 0.140 |
Why?
|
Embolism | 1 | 2020 | 399 | 0.140 |
Why?
|
Fibrin | 2 | 2019 | 507 | 0.140 |
Why?
|
Intracranial Embolism | 1 | 2018 | 189 | 0.140 |
Why?
|
Platelet Aggregation | 2 | 2020 | 771 | 0.140 |
Why?
|
Heparin | 2 | 2022 | 1634 | 0.130 |
Why?
|
Phlebography | 1 | 2017 | 326 | 0.130 |
Why?
|
Disability Evaluation | 3 | 2019 | 1835 | 0.130 |
Why?
|
Aneurysm, Ruptured | 1 | 2020 | 464 | 0.120 |
Why?
|
Time Factors | 12 | 2021 | 39967 | 0.120 |
Why?
|
Hypotension | 1 | 2021 | 879 | 0.120 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1702 | 0.120 |
Why?
|
Endocarditis | 1 | 2019 | 348 | 0.120 |
Why?
|
Antihypertensive Agents | 2 | 2022 | 2024 | 0.120 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5840 | 0.120 |
Why?
|
Trachea | 1 | 2020 | 1089 | 0.110 |
Why?
|
Blood Flow Velocity | 1 | 2018 | 1371 | 0.110 |
Why?
|
Retrospective Studies | 19 | 2024 | 80636 | 0.110 |
Why?
|
Recombinant Proteins | 2 | 2020 | 6534 | 0.110 |
Why?
|
Monitoring, Intraoperative | 1 | 2020 | 942 | 0.110 |
Why?
|
Drug Resistance | 1 | 2019 | 1596 | 0.110 |
Why?
|
Acute Disease | 2 | 2021 | 7237 | 0.110 |
Why?
|
Radiography, Interventional | 1 | 2020 | 1121 | 0.110 |
Why?
|
Thromboembolism | 1 | 2019 | 995 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3084 | 0.100 |
Why?
|
Surgery, Computer-Assisted | 1 | 2020 | 1007 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3204 | 0.100 |
Why?
|
Fibrinogen | 1 | 2015 | 888 | 0.100 |
Why?
|
Patient Transfer | 1 | 2019 | 794 | 0.100 |
Why?
|
Neutrophil Activation | 2 | 2024 | 180 | 0.090 |
Why?
|
Suction | 2 | 2024 | 266 | 0.090 |
Why?
|
Intraoperative Complications | 1 | 2018 | 1165 | 0.090 |
Why?
|
Animals | 10 | 2024 | 168459 | 0.090 |
Why?
|
Radiosurgery | 1 | 2020 | 1342 | 0.090 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2018 | 9000 | 0.090 |
Why?
|
Combined Modality Therapy | 3 | 2022 | 8529 | 0.080 |
Why?
|
Hemorrhage | 1 | 2021 | 3424 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 5 | 2020 | 20570 | 0.080 |
Why?
|
Single-Blind Method | 2 | 2024 | 1572 | 0.080 |
Why?
|
Lipoproteins, HDL | 1 | 2013 | 676 | 0.080 |
Why?
|
Disabled Persons | 1 | 2018 | 1225 | 0.080 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 2645 | 0.080 |
Why?
|
Middle Cerebral Artery | 2 | 2023 | 275 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 2 | 2020 | 4063 | 0.070 |
Why?
|
Heart Diseases | 1 | 2020 | 2781 | 0.070 |
Why?
|
Cohort Studies | 5 | 2022 | 41487 | 0.070 |
Why?
|
Catheters | 2 | 2020 | 427 | 0.070 |
Why?
|
DNA | 1 | 2020 | 7212 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 10209 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3600 | 0.070 |
Why?
|
Pandemics | 3 | 2020 | 8654 | 0.070 |
Why?
|
Fluoroscopy | 2 | 2020 | 947 | 0.060 |
Why?
|
Anticoagulants | 1 | 2020 | 4812 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2020 | 3408 | 0.060 |
Why?
|
Peyer's Patches | 1 | 2024 | 120 | 0.060 |
Why?
|
Cerebellum | 1 | 2011 | 1501 | 0.060 |
Why?
|
Follow-Up Studies | 6 | 2021 | 39106 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2024 | 11460 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15266 | 0.050 |
Why?
|
Odds Ratio | 3 | 2021 | 9646 | 0.050 |
Why?
|
Weather | 1 | 2023 | 231 | 0.050 |
Why?
|
Risk Factors | 8 | 2022 | 74206 | 0.050 |
Why?
|
Angiotensins | 1 | 2022 | 143 | 0.050 |
Why?
|
Superior Sagittal Sinus | 1 | 2021 | 15 | 0.050 |
Why?
|
Triage | 2 | 2019 | 986 | 0.050 |
Why?
|
Algorithms | 2 | 2020 | 14031 | 0.050 |
Why?
|
Chi-Square Distribution | 2 | 2017 | 3416 | 0.050 |
Why?
|
Infarction, Anterior Cerebral Artery | 1 | 2020 | 12 | 0.050 |
Why?
|
Infarction, Posterior Cerebral Artery | 1 | 2020 | 15 | 0.050 |
Why?
|
Paris | 1 | 2020 | 41 | 0.050 |
Why?
|
Physicians | 1 | 2019 | 4591 | 0.050 |
Why?
|
Adult | 9 | 2023 | 221177 | 0.040 |
Why?
|
Plasma Cells | 1 | 2024 | 599 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2024 | 978 | 0.040 |
Why?
|
Erythrocytes | 2 | 2020 | 2413 | 0.040 |
Why?
|
Plasminogen Activators | 1 | 2020 | 199 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2024 | 606 | 0.040 |
Why?
|
Aspirin | 2 | 2022 | 3133 | 0.040 |
Why?
|
Mutation | 1 | 2024 | 30052 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2020 | 397 | 0.040 |
Why?
|
Prognosis | 4 | 2024 | 29625 | 0.040 |
Why?
|
Punctures | 1 | 2020 | 366 | 0.040 |
Why?
|
Carotid Arteries | 1 | 2023 | 941 | 0.040 |
Why?
|
Cerebral Veins | 1 | 2020 | 157 | 0.040 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2020 | 344 | 0.040 |
Why?
|
Cerebral Arteries | 1 | 2020 | 490 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 781 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3245 | 0.040 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2019 | 945 | 0.040 |
Why?
|
Mortality | 2 | 2019 | 2901 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2019 | 15631 | 0.030 |
Why?
|
Blood Coagulation Disorders | 1 | 2020 | 350 | 0.030 |
Why?
|
Perfusion Imaging | 1 | 2018 | 196 | 0.030 |
Why?
|
Hospital Mortality | 2 | 2020 | 5294 | 0.030 |
Why?
|
Patient Selection | 2 | 2018 | 4244 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2019 | 11076 | 0.030 |
Why?
|
von Willebrand Factor | 1 | 2019 | 673 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2019 | 1848 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2022 | 1039 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2019 | 1596 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 1516 | 0.030 |
Why?
|
Microsurgery | 1 | 2020 | 795 | 0.030 |
Why?
|
Catheterization | 1 | 2020 | 1428 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2017 | 590 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2024 | 22176 | 0.030 |
Why?
|
Emergencies | 1 | 2020 | 1217 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22169 | 0.030 |
Why?
|
Streptococcus pneumoniae | 1 | 2019 | 730 | 0.030 |
Why?
|
Visual Fields | 1 | 2020 | 1062 | 0.030 |
Why?
|
Glycoproteins | 1 | 2021 | 2203 | 0.030 |
Why?
|
Vision Disorders | 1 | 2020 | 1088 | 0.030 |
Why?
|
Rupture, Spontaneous | 1 | 2014 | 362 | 0.030 |
Why?
|
Age Factors | 2 | 2020 | 18395 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4853 | 0.030 |
Why?
|
Aorta | 1 | 2020 | 2042 | 0.030 |
Why?
|
Logistic Models | 2 | 2017 | 13255 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2024 | 4544 | 0.020 |
Why?
|
Mice | 3 | 2024 | 81525 | 0.020 |
Why?
|
Cardiac Imaging Techniques | 1 | 2014 | 267 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2019 | 1458 | 0.020 |
Why?
|
Ischemia | 1 | 2019 | 1882 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 2017 | 1474 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2013 | 1379 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5247 | 0.020 |
Why?
|
Echocardiography, Transesophageal | 1 | 2014 | 1086 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5871 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2011 | 2219 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14666 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12974 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12341 | 0.020 |
Why?
|
Young Adult | 2 | 2020 | 59243 | 0.010 |
Why?
|
Brain | 2 | 2020 | 27112 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 88319 | 0.010 |
Why?
|
Echocardiography | 1 | 2014 | 4989 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26125 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2013 | 4431 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20098 | 0.010 |
Why?
|
Cell Line | 1 | 2013 | 15601 | 0.010 |
Why?
|
Child | 1 | 2023 | 80153 | 0.010 |
Why?
|